Purpose | Announcement Date | Meeting Date |
---|---|---|
EGM | 13 Nov 2023 | 15 Dec 2023 |
COM 15/12/2023 Notice of the meeting of the Equity Shareholders and Unsecured Creditors of the Company pursuant to the Order of the National Company Law Tribunal, Hyderabad Bench- 1 (As Per BSE Announcement Dated on 10/11/2023) Copy of Newspaper Advertisement for notice of the meeting of the equity Shareholders and unsecured creditors of the Company pursuant to the order of the National Company Law Tribunal , Hyderabad Bench- 1 (As Per BSE Announcement dated on 11.11.2023) Outcome/ Summary proceedings of NCLT convened Meetings of Equity Shareholders and Trade Creditors of MedPlus Health Services Limited pursuant to NCLT order dated November 7, 2023 in connection with to consider and approve the Scheme of Amalgamation of MHS Pharmaceuticals Private Limited (Transferor Company) with MedPlus Health Services Limited (Transferee Company) and their respective shareholders and creditors (As per BSE Announcement Dated on 15/12/2023) Notice of the meeting of the Equity Shareholders and Unsecured Creditors of the Company pursuant to the Order of the National Company Law Tribunal, Hyderabad Bench- 1 (As Per BSE Announcement Dated on 17/12/2023) |
Invesco Mutual Fund and Kotak Mahindra Mutual Fund bought 2.6% apiece, while Franklin Templeton Mutual Fund purchased 1.3% stake.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice